Stock Information
Relay Therapeutics Inc (RLAY)
Ticker Symbol: RLAY
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $3,347.53 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -1.565
Revenue (TTM): $0.06 M
Dividend Yield: N/A%
ROE: -43.94%
Latest News
-
Goldman Sachs Maintains Buy on Relay Therapeutics, Raises Price Target to $31
Tue, Jul 21, 2026 8:45 AM
Key Financials
Financial data not available